An exploratory study of Elafibranor in newly diagnosed patients with primary biliary cholangitis
Latest Information Update: 01 Oct 2021
At a glance
- Drugs Elafibranor (Primary)
- Indications Primary biliary cirrhosis
- Focus Therapeutic Use
- 29 Sep 2021 According to a GENFIT media release, data expected in third quarter of 2022.
- 18 May 2021 New trial record
- 11 May 2021 According to a GENFIT media release, the company expect to initiate this trial in 2021 with data expected end of 2022.